Roux-en-Y Gastric Bypass: Clinical Trial
ERAPT
Roux-en-Y Gastric Bypass as a Therapeutic Option for Patients With Indication for Bariatric and / or Metabolic Surgery: Clinical Trial
1 other identifier
interventional
33
1 country
1
Brief Summary
The present study aims to describe the results of a modified gastric bypass surgery to ensure endoscopic access to the excluded remaining stomach, as well as to monitor the clinical conditions of comorbidities and the patient's quality of life, since associated complications can be found to the excluded stomach, such as: bile reflux, gastritis and / or gastric and duodenal ulcer, H. pylori infection, bleeding, gastric polyps and the possibility of gastric cancer in patients undergoing RYGB (Roux-en-Y gastric bypass), with one of the probable factors being the occurrence reflux of the duodenal content into the excluded portion of the stomach. In this sense, based on technical concepts of an established surgical procedure, the RYGB, the present project is not a proposal for a new procedure, but an adaptation of an existing technique. The proposal of the present study is about adaptations in RYGB surgery, which will enable endoscopic access to the remaining stomach, through the creation of a gastric communication.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable obesity
Started Jan 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 18, 2020
CompletedFirst Submitted
Initial submission to the registry
August 7, 2020
CompletedFirst Posted
Study publicly available on registry
December 2, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 10, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 29, 2021
CompletedDecember 2, 2020
November 1, 2020
1.1 years
August 7, 2020
November 25, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (11)
Assessment of excess body weight loss
During postoperative visits, the patient's body weight loss obtained after surgery will be assessed by means of absolute BMI values measured after the operative period and the percentage of lost BMI.
3 months after surgery
Assessment of excess body weight loss
During postoperative visits, the patient's body weight loss obtained after surgery will be assessed by means of absolute BMI values measured after the operative period and the percentage of lost BMI.
6 months after surgery
Assessment of excess body weight loss
During postoperative visits, the patient's body weight loss obtained after surgery will be assessed by means of absolute BMI values measured after the operative period and the percentage of lost BMI.
9 months after surgery
Assessment of excess body weight loss
During postoperative visits, the patient's body weight loss obtained after surgery will be assessed by means of absolute BMI values measured after the operative period and the percentage of lost BMI.
12 months after surgery
Assessment of excess body weight loss
During postoperative visits, the patient's body weight loss obtained after surgery will be assessed by means of absolute BMI values measured after the operative period and the percentage of lost BMI.
18 months after surgery
Assessment of the remaining stomach and duodenum access by endoscopy exam performed on each patient
To assess access to the remaining stomach and duodenum, endoscopies will be performed after surgery by a professional from the endoscopy team at Hospital Geral Alberto Rassi.
3 months after surgery
Assessment of the remaining stomach and duodenum access by endoscopy exam performed on each patient
To assess access to the remaining stomach and duodenum, endoscopies will be performed after surgery by a professional from the endoscopy team at Hospital Geral Alberto Rassi.
12 months after surgery
Assessment of the remaining stomach and duodenum access by endoscopy exam performed on each patient
To assess access to the remaining stomach and duodenum, endoscopies will be performed after surgery by a professional from the endoscopy team at Hospital Geral Alberto Rassi.
18 months after surgery
Application of the BAROS (Bariatric Analysis and Reporting Outcome) questionnaire
The questionnaire used for subjective evaluation of the surgery result and the post-operative quality of life adopted will be the BAROS (Bariatric Analysis and Reporting Outcome). The BAROS protocol consists of three major research areas (weight loss, medical conditions and quality of life questionnaire), from which a maximum score of three points is obtained for each category, totaling a maximum of nine points. The questionnaire will be applied by trained researchers.
6 months after surgery
Application of the BAROS (Bariatric Analysis and Reporting Outcome) questionnaire
The questionnaire used for subjective evaluation of the surgery result and the post-operative quality of life adopted will be the BAROS (Bariatric Analysis and Reporting Outcome). The BAROS protocol consists of three major research areas (weight loss, medical conditions and quality of life questionnaire), from which a maximum score of three points is obtained for each category, totaling a maximum of nine points. The questionnaire will be applied by trained researchers.
12 months after surgery
Application of the BAROS (Bariatric Analysis and Reporting Outcome) questionnaire
The questionnaire used for subjective evaluation of the surgery result and the post-operative quality of life adopted will be the BAROS (Bariatric Analysis and Reporting Outcome). The BAROS protocol consists of three major research areas (weight loss, medical conditions and quality of life questionnaire), from which a maximum score of three points is obtained for each category, totaling a maximum of nine points. The questionnaire will be applied by trained researchers.
18 months after surgery
Secondary Outcomes (1)
Weight loss assessment through exams and interviews
18 months
Study Arms (1)
Single-arm-study
OTHERProspective clinical trial with intentional sample selection that aims to describe the results of the gastric Bypass surgery modified by De Melo, for the purpose of endoscopic access to the excluded remaining stomach, as well as to monitor the clinical conditions of comorbidities and the quality of life of the patient.
Interventions
Roux-en-Y gastric bypass: Stapling and reduction of the gastric chamber of approximately 18 cm, followed by anastomosis with a deviated bowel, and another bowel anastomosis with a bowel in a lower portion, for deviation of biliopancreatic secretions. Maintenance of a gastro-gastric communication of approximately 1 cm between the functional gastric pouch and the excluded stomach for endoscopic access.
Eligibility Criteria
You may qualify if:
- Individuals of both sexes;
- Minimum age of 18 and maximum of 70 years for a BMI greater than or equal to 35 kg / m2;
- Age from 30 to 70 years for BMI greater than or equal to 30 and less than or equal to 34.9 kg / m2, associated with diabetes;
- Absence of contraindications for the surgical procedure.
You may not qualify if:
- Abandonment of pre-operative multiprofessional follow-up before 12 months;
- Members of vulnerable groups;
- Uncompensated psychiatric disorders or cognitive impairment confirmed by a psychiatrist and / or psychologist;
- Abuse of alcohol or illicit drugs confirmed after evaluation by the psychiatrist and / or psychologist;
- Chronic diseases not related to obesity such as cancer, pneumopathy, nephropathy, heart disease, Parkinson's and Alzheimer's.
- Patients already undergoing other bariatric surgeries.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Paulo Reis Esselin de Melo
Goiânia, Goiás, 74110-010, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paulo Reis Esselin de Melo
Hospital Geral de Goiânia
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 7, 2020
First Posted
December 2, 2020
Study Start
January 18, 2020
Primary Completion
February 10, 2021
Study Completion
April 29, 2021
Last Updated
December 2, 2020
Record last verified: 2020-11
Data Sharing
- IPD Sharing
- Will not share